242 related articles for article (PubMed ID: 30243716)
1. Production and characterization of monoclonal antibody against a triple negative breast cancer cell line.
Ghaderi F; Ahmadvand S; Ramezani A; Montazer M; Ghaderi A
Biochem Biophys Res Commun; 2018 Oct; 505(1):181-186. PubMed ID: 30243716
[TBL] [Abstract][Full Text] [Related]
2. Production of anti-tumor human monoclonal antibodies using different approaches.
Liu H; Xu ZL; Wang Y; Yang L; Feng O; Li Y; Wang YM; Zhang GG
Hum Antibodies Hybridomas; 1993 Jan; 4(1):2-8. PubMed ID: 8381684
[TBL] [Abstract][Full Text] [Related]
3. Production of anti-CD14 monoclonal antibody using synthetic peptide of human CD14 as immunizing antigen.
Maleki LA; Shanehbandi D; Majidi J; Yusefi M; Abdolalizadeh J; Orangi M; Baradaran B
Hum Antibodies; 2013; 22(3-4):67-71. PubMed ID: 24961864
[TBL] [Abstract][Full Text] [Related]
4. Preparation of monoclonal antibody against apoptosis-associated antigens of hepatoma cells by subtractive immunization.
Yang LJ; Wang WL
World J Gastroenterol; 2002 Oct; 8(5):808-14. PubMed ID: 12378620
[TBL] [Abstract][Full Text] [Related]
5. Production of a Mouse Monoclonal Antibody Against Mortalin by Whole Cell Immunization.
Rezaei M; Ghaderi A
Monoclon Antib Immunodiagn Immunother; 2017 Aug; 36(4):169-175. PubMed ID: 28719245
[TBL] [Abstract][Full Text] [Related]
6. Development of high-affinity monoclonal antibody using CD44 overexpressed cells as a candidate for targeted immunotherapy and diagnosis of acute myeloid leukemia.
Amanzadeh A; Heidarnejad F; Abdollahpour-Alitappeh M; Molla-Kazemiha V; Yari S; Hadizadeh-Tasbiti A; Habibi-Anbouhi M; Abolhassani M; Shokrgozar MA
Hum Antibodies; 2017; 26(1):7-15. PubMed ID: 28269763
[TBL] [Abstract][Full Text] [Related]
7. Production and characterization of mouse monoclonal antibodies to human bladder tumor-associated antigens.
Young DA; Prout GR; Lin CW
Cancer Res; 1985 Sep; 45(9):4439-46. PubMed ID: 3896480
[TBL] [Abstract][Full Text] [Related]
8. Monoclonal antibodies recognizing tumor-associated antigen of human ovarian mucinous cystadenocarcinomas.
Bhattacharya M; Chatterjee SK; Barlow JJ; Fuji H
Cancer Res; 1982 May; 42(5):1650-4. PubMed ID: 6175395
[TBL] [Abstract][Full Text] [Related]
9. Monoclonal antibodies against human breast tumor-associated antigens: characterization of B21 antigen.
Annibali NV; San Martino JA; Baldi A
J Natl Cancer Inst; 1994 Feb; 86(3):215-21. PubMed ID: 8283494
[TBL] [Abstract][Full Text] [Related]
10. Human monoclonal antibody reactive to stomach cancer produced by mouse-human hybridoma technique.
Yoshikawa K; Ueda R; Obata Y; Utsumi KR; Notake K; Takahashi T
Jpn J Cancer Res; 1986 Nov; 77(11):1122-33. PubMed ID: 3098722
[TBL] [Abstract][Full Text] [Related]
11. Specificity and properties of MAb RS7-3G11 and the antigen defined by this pancarcinoma monoclonal antibody.
Stein R; Basu A; Chen S; Shih LB; Goldenberg DM
Int J Cancer; 1993 Dec; 55(6):938-46. PubMed ID: 8253531
[TBL] [Abstract][Full Text] [Related]
12. Generation and characterization of a panel of monoclonal antibodies specific for human fibroblast growth factor receptor 4 (FGFR4).
Chen C; Patel S; Corisdeo S; Liu X; Micolochick H; Xue J; Yang Q; Lei Y; Wang B; Soltis D
Hybridoma (Larchmt); 2005 Jun; 24(3):152-9. PubMed ID: 15943563
[TBL] [Abstract][Full Text] [Related]
13. Production of murine monoclonal antibodies against cell-surface antigens of human ovarian carcinoma.
Bhattacharya M; Chatterjee SK; Gangopadhyay A; Barlow JJ
J Surg Oncol; 1985 Dec; 30(4):209-14. PubMed ID: 2417057
[TBL] [Abstract][Full Text] [Related]
14. Monoclonal antibodies against antigens on breast cancer cells.
Stähli C; Takacs B; Miggiano V; Staehelin T; Carmann H
Experientia; 1985 Nov; 41(11):1377-81. PubMed ID: 2415385
[TBL] [Abstract][Full Text] [Related]
15. RP215 single chain fragment variable and single domain recombinant antibodies induce cell cycle arrest at G0/G1 phase in breast cancer.
Yu F; Wang Y; Xiao Y; He Y; Luo C; Duan D; Li C; Xu S; Xiang T
Mol Immunol; 2014 May; 59(1):100-9. PubMed ID: 24534066
[TBL] [Abstract][Full Text] [Related]
16. Production and characterization of monoclonal antibodies against human IgG in Balb/c mouse.
Majidi J; Baradaran B; Hassan ZM; Mostafaie A
Hum Antibodies; 2005; 14(1-2):1-5. PubMed ID: 16424594
[TBL] [Abstract][Full Text] [Related]
17. Production of a monoclonal antibody against a human osteosarcoma xenograft.
Chin C; Marks A; Yeger H; Kahn H; Baumal R
Hybridoma; 1986; 5(4):339-46. PubMed ID: 3542807
[TBL] [Abstract][Full Text] [Related]
18. [Preparation and identification of monoclonal antibodies against Type M/N and Glycophorin A/B].
Chen Q; Cao H; Zhang HY; Gao XF; Wang F; Li HD
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2007 Jun; 23(6):556-8. PubMed ID: 17553354
[TBL] [Abstract][Full Text] [Related]
19. Development and characterization of monoclonal antibodies against human CD20 in Balb/c mice.
Sepehr KS; Baradaran B; Majidi J; Abdolalizadeh J; Aghebati L; Shahneh FZ
Hum Antibodies; 2012; 21(3-4):57-64. PubMed ID: 23549022
[TBL] [Abstract][Full Text] [Related]
20. Development of a new anti-CD123 monoclonal antibody to target the human CD123 antigen as an acute myeloid leukemia cancer stem cell biomarker.
Abdollahpour-Alitappeh M; Razavi-Vakhshourpour S; Abolhassani M
Biotechnol Appl Biochem; 2018 Nov; 65(6):841-847. PubMed ID: 29972607
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
